YTHDF1 influences tumor antigen cross-presentation in dendritic cells and the cross-priming of CD8+ T cells [44], whereas its knockdown boosts the antitumor activity of specific CD8+ T cell populations [45]. Here, CD8A is linked to neoplasm.